Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 3
2006 3
2007 6
2008 2
2009 6
2010 13
2011 4
2012 13
2013 11
2014 15
2015 24
2016 22
2017 22
2018 15
2019 15
2020 31
2021 33
2022 33
2023 27
2024 30
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

310 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean fengtai zhu (240 results)?
Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial.
Zhao FH, Wu T, Hu YM, Wei LH, Li MQ, Huang WJ, Chen W, Huang SJ, Pan QJ, Zhang X, Hong Y, Zhao C, Li Q, Chu K, Jiang YF, Li MZ, Tang J, Li CH, Guo DP, Ke LD, Wu X, Yao XM, Nie JH, Lin BZ, Zhao YQ, Guo M, Zhao J, Zheng FZ, Xu XQ, Su YY, Zhang QF, Sun G, Zhu FC, Li SW, Li YM, Pan HR, Zhang J, Qiao YL, Xia NS. Zhao FH, et al. Lancet Infect Dis. 2022 Dec;22(12):1756-1768. doi: 10.1016/S1473-3099(22)00435-2. Epub 2022 Aug 26. Lancet Infect Dis. 2022. PMID: 36037823 Clinical Trial.
Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Huang S, Zhang X, Su Y, Zhuang C, Tang Z, Huang X, Chen Q, Zhu K, Hu X, Ying D, Liu X, Jiang H, Zang X, Wang Z, Yang C, Liu D, Wang Y, Tang Q, Shen W, Cao H, Pan H, Ge S, Huang Y, Wu T, Zheng Z, Zhu F, Zhang J, Xia N. Huang S, et al. Among authors: zhu f. Lancet. 2024 Mar 2;403(10429):813-823. doi: 10.1016/S0140-6736(23)02234-1. Epub 2024 Feb 19. Lancet. 2024. PMID: 38387470 Clinical Trial.
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trial.
Zhu FC, Zhong GH, Huang WJ, Chu K, Zhang L, Bi ZF, Zhu KX, Chen Q, Zheng TQ, Zhang ML, Liu S, Xu JB, Pan HX, Sun G, Zheng FZ, Zhang QF, Yi XM, Zhuang SJ, Huang SJ, Pan HR, Su YY, Wu T, Zhang J, Xia NS. Zhu FC, et al. Lancet Infect Dis. 2023 Nov;23(11):1313-1322. doi: 10.1016/S1473-3099(23)00275-X. Epub 2023 Jul 17. Lancet Infect Dis. 2023. PMID: 37475116 Clinical Trial.
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, Wu SP, Wang BS, Wang Z, Wang L, Jia SY, Jiang HD, Wang L, Jiang T, Hu Y, Gou JB, Xu SB, Xu JJ, Wang XW, Wang W, Chen W. Zhu FC, et al. Lancet. 2020 Jun 13;395(10240):1845-1854. doi: 10.1016/S0140-6736(20)31208-3. Epub 2020 May 22. Lancet. 2020. PMID: 32450106 Free PMC article. Clinical Trial.
The vaccines-associated Arthus reaction.
Peng B, Wei M, Zhu FC, Li JX. Peng B, et al. Hum Vaccin Immunother. 2019;15(11):2769-2777. doi: 10.1080/21645515.2019.1602435. Epub 2019 May 3. Hum Vaccin Immunother. 2019. PMID: 30945978 Free PMC article. Review.
Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial.
Alexandra Echeverria Proano D, Zhu F, Sun X, Zoco J, Soni J, Parmar N, Ali SO; Zoster-076 Study Group. Alexandra Echeverria Proano D, et al. Among authors: zhu f. Hum Vaccin Immunother. 2024 Dec 31;20(1):2351584. doi: 10.1080/21645515.2024.2351584. Epub 2024 Jun 5. Hum Vaccin Immunother. 2024. PMID: 38838170 Free PMC article. Clinical Trial.
Human Infection with an Avian-Origin Influenza A (H10N3) Virus.
Qi X, Qiu H, Hao S, Zhu F, Huang Y, Xu K, Yu H, Wang D, Zhou L, Dai Q, Zhou Y, Wang S, Huang H, Yu S, Huo X, Chen K, Liu J, Hu J, Wu M, Bao C. Qi X, et al. Among authors: zhu f. N Engl J Med. 2022 Mar 17;386(11):1087-1088. doi: 10.1056/NEJMc2112416. N Engl J Med. 2022. PMID: 35294820 No abstract available.
Advances in the progress of monoclonal antibodies for rabies.
Fan L, Zhang L, Li J, Zhu F. Fan L, et al. Among authors: zhu f. Hum Vaccin Immunother. 2022 Dec 31;18(1):2026713. doi: 10.1080/21645515.2022.2026713. Epub 2022 Feb 16. Hum Vaccin Immunother. 2022. PMID: 35172707 Free PMC article. Review.
The COVID-19 Vaccine in Clinical Trials: Where Are We Now?
Jiang HD, Li JX, Zhang P, Huo X, Zhu FC. Jiang HD, et al. Infect Dis Immun. 2021 Apr 20;1(1):43-51. doi: 10.1097/ID9.0000000000000003. eCollection 2021 Apr. Infect Dis Immun. 2021. PMID: 38630107 Free PMC article. Review.
310 results